Skip to main content
MET logo

MetLife, Inc. (MET) Stock: Price, Forecast & Analyst Target

MetLife, Inc. (MET) — MoonshotScore 88/100 (Exceptional band), calculated Nov 18, 2026. Price $99.79 (-1.68%), as of the Nov 18, 2026 trading session; market cap $62.7B. Expected results Feb 3, 2027.

Educational signal · not a buy or sell recommendation · How to read this

$99.79 −$1.71 (-1.68%) Market Cap $62.7B

MetLife, Inc. · MET · NYSE · Financial Services · Insurance - Life

Research dated 2026-09-12: MetLife is a global insurer, employee-benefits provider, retirement-risk carrier and asset manager whose results depend on more than policy sales. The core question is whether recurring insurance and fee activity can support steadier earnings while investment returns and large contractual obligations keep reported profit volatile.

Price as of Nov 18, 2026

Key Statistics

88 of 100

MoonshotScore v2 · MetLife (MET)

Exceptional
Business Quality Average (52)
Financial Safety Sound (61)
Valuation Cheap (92)
Growth Durability Compounding (91)
Momentum Surging (96)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Elite growth, at a dirt-cheap price, though quality is only middling; the market is already moving on it. Business Quality: Average; Financial Safety: Sound; Valuation: Cheap; Growth Durability: Compounding; Momentum: Surging.

  • EPS beat 0 of the last 4 reports
  • Altman Z 0.68 · Piotroski F 8
  • ROE 19.9% · ROA 0.6% · current ratio 1.87

Helping: an attractive price, durable growth, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for MET (57 recorded, newest six shown)
RecordedScoreBand
92Exceptional
93Exceptional
92Exceptional
92Exceptional
88Exceptional
88Exceptional

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$99.79
Change on the day-1.68%
52-week range$67.33–$106.72
Market capitalisation$62.7B—
Price / earnings (trailing)13.15
Shares traded on the day4.27M
Beta (volatility vs the S&P 500)0.77

Why MetLife scores 88

Dr. Mira Sol, the Stock Expert AI TV data character
Momentum carries the score; Business Quality is what holds it back.
Dr. Mira Sol · Data scientist, Stock Expert AI TV (fictional AI character)
88Exceptional
  • Business Quality52
  • Financial Safety61
  • Valuation92
  • Growth Durability91
  • Momentum96

Share price, last 12 months +31.7%

$77.18 $101.67

What the price assumes

-14.8% a year of free-cash-flow growth for ten years is what a $64.61B market value ( snapshot) asks for.

  • Price implies, next ten years-14.8%
  • Free cash flow, last 5 years9.5%
  • Revenue, last 5 years2.6%
  • Analysts' revenue path, 2026–20295.4%

The price asks for less growth than the business has been producing. The question it leaves open is how long that pace lasts, not whether it exists.

Reverse discounted cash flow: 10% discount rate, 3% growth after year ten, starting from trailing twelve months free cash flow of $15.00B. Inputs: FMP statements, estimates and quote.

How the stock reacts to earnings

EPS beat in 6 of the last 12 reports (2024–2026); the stock still fell the next session after 5 of those beats. Average first-session move: 2.6% either way.

  1. -7.7%Jan ’24
  2. -1.2%May ’24
  3. -1.3%Jul ’24
  4. -5.3%Oct ’24
  5. -1.1%Feb ’25
  6. -0.9%Apr ’25
  7. -1.4%Aug ’25
  8. -4.4%Nov ’25
  9. -2.1%Feb ’26
  10. -1.4%May ’26
  11. +4.0%Aug ’26
  12. -0.9%Nov ’26
Next-session move EPS beat (6) EPS in line (2) EPS miss (4)
Every report, with revenue and five-session moves
Moves run from the close before the report to the first and fifth closes after it.
ReportEPSRevenueNext session5 sessions
In lineBeat-0.9%—
BeatMiss+4.0%+0.6%
BeatBeat-1.4%-2.3%
BeatMiss-2.1%+2.6%
BeatMiss-4.4%+0.9%
MissMiss-1.4%+3.3%
MissIn line-0.9%+0.4%
MissMiss-1.1%-2.2%
MissMiss-5.3%+0.5%
BeatMiss-1.3%-10.4%
In lineMiss-1.2%+0.8%
BeatBeat-7.7%-5.4%

Misses cost real money here: the average first-session move after a miss was -2.2%.

What management is saying differently

Management's own words on the Q3 FY2026 call () against Q2 FY2026 (). Analysts' questions are left out.

  • New this call: “notable items”, “excluding notable”, “fixed income”, “actuarial assumption” — none of them came up in Q2 FY2026.
  • Getting louder: “cash flow” (2 → 8 mentions), “attractive returns” (3 → 7 mentions), “free cash” (2 → 7 mentions).
  • Gone quiet: “earnings power”, “region sales” — regular themes last call, absent this time.
  • Tone: Cautious words such as “may”, “could” and “headwind” fell from 3.5 to 1.9 per 1,000 words, and confident words such as “record” and “strong” fell from 8.8 to 7.4.

Management sounded more assured than a quarter earlier — fewer hedging words, more of the confident kind.

Our track record on this stock

Since the score went from 89 to 88 while the share price moved +3.7% through .

MoonshotScore (0–100, band floors 45 · 65 · 80) Share price, scaled to its own range

The score has stayed in the Exceptional band across the stretch we have recorded; we grade each band change three months after it happens.

The crowd against our signals

  • Analysts: 79% of 33 rate it a buy; the average target sits +8.9% from the price of $99.79.
  • Last 90 days: 1 upgrade and 0 downgrades among 11 rating actions.
  • Our signals: Exceptional band; strongest pillar Momentum (96), weakest Business Quality (52).

Here we and the crowd agree.

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 18, 2026: low $68, high $103, latest $100. 4 reported quarters marked, 4 above and 0 below the recorded estimate. $103 $68 high $103 Feb 4, 2026 · Earnings results · reported above the recorded estimate · close $761May 6, 2026 · Earnings results · reported above the recorded estimate · close $782Aug 5, 2026 · Earnings results · reported above the recorded estimate · close $983Nov 4, 2026 · Earnings results · reported above the recorded estimate · close $984 Oct 17, 2025 Nov 18, 2026 · $100 $78Oct 17, 2025$80Oct 31, 2025$79Nov 14, 2025$77Nov 28, 2025$82Dec 12, 2025$80Dec 26, 2025$79Jan 9, 2026$76Jan 23, 2026$76Feb 6, 2026$79Feb 20, 2026$72Mar 6, 2026$69Mar 20, 2026$71Apr 2, 2026$78Apr 17, 2026$80May 1, 2026$80May 15, 2026$83May 29, 2026$89Jun 12, 2026$86Jun 26, 2026$92Jul 10, 2026$95Jul 24, 2026$98Aug 7, 2026$94Aug 21, 2026$98Sep 4, 2026$97Sep 18, 2026$94Oct 2, 2026$101Oct 16, 2026$100Oct 30, 2026$103Nov 13, 2026

Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.

Events behind the price

  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate

Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.

Upcoming events

As of

  1. Next results dueProvider estimate
How to read these dates

Estimated dates can change.

What to watch next

Other perspectives

Council score for MetLife (MET): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Neutral
Financial Safety Moderate
Valuation Strong
Growth Durability Strong
Momentum Strong

Legends Council

6 lenses, 6 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Neutral read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Neutral read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Neutral read

Read on: Nov 18, 2026

Munger's Mindset

Balance Sheet & Valuation

Financial Health Neutral
Margin of Safety Undervalued
Profit Margin Neutral
Revenue Growth Moderate
Debt/Equity Negative
ROE Moderate
Gross Margin Neutral

Read on: Nov 19, 2026

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

The Munger lens reads the current price as undervalued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is MetLife (MET), and what does it report?

Short answer · as of

MetLife sells life and health protection, workplace benefits, annuities, pension risk transfers and investment products across the United States and several international regions.

It also earns fees from administrative-only arrangements, vision services, prepaid legal plans and investment management, so revenue is not simply a measure of life-insurance premiums.

The income statement combines insurance activity, service fees and investment-sensitive businesses. The earnings measure compared with analyst estimates also differs materially from diluted earnings in the quarterly statement, making the underlying basis important when judging performance.

2 · Latest results

What do the latest results show for MetLife (MET)?

Revenue softened from the preceding period, while operating profit, net income and diluted earnings fell more sharply. The latest consensus comparison was mixed: reported earnings cleared expectations, but revenue did not, after the preceding release had beaten expectations on each measure.

The available results establish the change but do not assign it to a particular operating cause. Management expects stronger private-equity returns, especially from venture holdings, as offering activity and public-market valuations improve; that is an outlook for investment contribution, not an explanation of the latest decline.

Where is operating spending going?

Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.

Period endRevenueR&DSG&AFMP standardized operating result
Sep 30, 2026Not availableNot availableNot availableNot available
Jun 30, 2026Not availableNot availableNot availableNot available
Mar 31, 2026Not availableNot availableNot availableNot available
Dec 31, 2025Not availableNot availableNot availableNot available
How to read these figures

Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.

Did results meet expectations?

Reported earnings and revenue alongside the estimates recorded by the provider.

Latest report · revenue
$20.52B Nov 4, 2026
Latest report · revenue estimate
$19.86B Nov 4, 2026
Latest report · revenue vs estimate
Above estimate Nov 4, 2026
Latest report · EPS vs estimate
Above estimate Nov 4, 2026
Report dateRevenue · reportedRevenue · estimateEPS · reportedEPS · estimate
Nov 4, 2026$20.52B$19.86B$2.7800$2.7700
Aug 5, 2026$19.07B$19.67B$2.4300$2.3000
May 6, 2026$19.68B$19.49B$2.4200$2.2700
Feb 4, 2026$23.81B$27.22B$2.5800$2.3400
How to read these figures

Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Sep 2025$16.88B$896M$1.22 (diluted)
Q4 FY2025$23.29B$809M$1.17 (diluted)
Q1 FY2026$18.62B$1.19B$1.74 (diluted)
Q2 FY2026$18.88B$736M$1.09 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for MetLife (MET)?

Short answer

Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.

Operating cash flow has remained positive across the reported periods, although its size varies considerably. Reported cash and short-term investments exceed debt, and the broader investment portfolio is substantial, but those assets sit inside an insurer carrying extensive policy and contractual liabilities; gross liquidity therefore should not be read as excess capital.

Profit is the more visible vulnerability. Annual revenue expanded while net income declined in the latest year, and quarterly margins remain modest, so changes in claims, credit experience or investment performance can have an outsized effect on equity returns even when revenue holds up.

Data-derived red flags

  • Financial-distress signal — its Altman Z-Score of 0.68 sits in the distress zone (elevated bankruptcy risk).
  • Inconsistent delivery — missed Wall Street EPS estimates in 0 of the last 4 reported quarters.
4 · What to check next?

What should you watch next at MetLife (MET)?

Short answer · as of

The next earnings report is expected on Feb 3, 2027.

Watch whether MetLife converts management's expected improvement in private-equity returns into stronger reported profit without relying on revenue growth alone. The more durable confirmation would be firmer operating income and net income alongside continued positive operating cash flow.

The scheduled earnings release also provides a clean test of recent expectations: analysts anticipate expansion in revenue and earnings over the forecast horizon, while the latest release paired an earnings beat with a revenue miss. Continued divergence would make the definition and source of earnings increasingly important.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does MetLife compare with its peers?

Short answer

MetLife's score ranks 3rd of 12 in the bounded comparison shown, against 11 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

MetLife differs from a narrowly focused life insurer because workplace benefits, administrative contracts, pension risk transfers, annuities, institutional products and asset management all contribute to the economic model. Its geographic reach also spreads activity across the United States, Asia, Latin America, Europe, the Middle East and Africa.

That breadth creates several earnings channels, but it also links shareholder returns to investment markets and long-duration obligations as well as insurance demand. Comparisons based only on premium growth or a standard life-insurer multiple can miss those differences.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Primerica, Inc. (PRI) Same industry, near in market value$294.92 Nov 18, 2026$8.95B96 5-pillar Nov 18, 2026
F&G Annuities & Life, Inc. (FGN) Same industry, near in market value$20.86 Nov 18, 2026$3.77B96 5-pillar Nov 18, 2026
MetLife (MET) — this page$99.79$62.7B88
Prudential Financial, Inc. (PRU) Named competitor$121.54 Nov 18, 2026$41.7B85 5-pillar Nov 18, 2026
Manulife Financial Corporation (MFC) Named competitor$42.22 Nov 19, 2026$69.8B79 5-pillar Nov 18, 2026
CNO Financial Group, Inc. (CNO) Same industry, near in market value$55.02 Nov 19, 2026$5.03B78 5-pillar Nov 18, 2026
Globe Life Inc. (GL) Same industry, near in market value$155.15 Nov 18, 2026$11.7B74 5-pillar Nov 18, 2026
AFLAC Incorporated (AFL) Named competitor$124.77 Nov 19, 2026$61.7B65 5-pillar Nov 18, 2026
Lincoln National Corporation (LNC) Same industry, near in market value$42.07 Nov 18, 2026$8.01B61 5-pillar Nov 18, 2026
Unum Group (UNM) Named competitor$76.39 Nov 18, 2026$11.8B56 5-pillar Nov 18, 2026
Prudential plc (PUK) Named competitor$24.78 Nov 19, 2026$30.2B48 5-pillar Nov 18, 2026
Brighthouse Financial, Inc. (BHFAL) Same industry, near in market value$14.77 Nov 18, 2026$2.49B31 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Financial Services stocks

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$103.00 – $112.00
Consensus target
$108.78
Median target
$110.00

Consensus record · Captured .

Measured against a quoted price of $99.79 (as of Nov 18, 2026).

Insider activity

Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Nov 10, 2026

Transactions
51
Identified insiders
15
Purchases
0
Sales
1
Other transactions
50

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held MET in their latest 13F filing, and what they did against the filing before it.

InvestorManager13F quarterPortfolio weightValueLast quarter
Bridgewater AssociatesFounded by Ray DalioQ3 20260.29%$66.35MAdded +13.4% shares

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about MetLife (MET)?

Read these with our analysis →

MET Financial Services Stock FAQ

The last 2 questions are answered from this page's own dated data, not from the research.

What does MetLife Group Benefits sell to employers?

Group Benefits supplies workplace protection such as life, dental, disability, vision, accident and health coverage, while administrative-only arrangements let employers retain some insurance risk and pay MetLife for administration.

Why do private-equity returns matter to MetLife earnings?

MetLife invests alongside its insurance and retirement businesses, so private-equity performance can affect investment contribution to profit. Management expects venture holdings to benefit from stronger offering activity and higher public-market valuations.

Is MetLife Holdings the same as the operating insurance business?

MetLife Holdings is a separately identified operating division within the wider company, which also reports businesses across the United States and international regions. The company therefore extends well beyond that portfolio.

Do MetLife insider records show open-market buying?

Recent insider activity is classified as awards and in-kind transactions, with no purchases or sales recorded in the stated window. That pattern describes transaction type, not insider intent.

What is the MET stock price today?

The last price recorded for MetLife, Inc. (MET), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the MET price target?

The analyst consensus price target for MetLife, Inc. (MET), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Reviewed by Sedat ANAK, Founder and Editor-in-Chief, on 2026-11-07.

Sources: the source register lists the 43 figures on this page — 1 from SEC filings and earnings calls, 36 from Financial Modeling Prep (FMP), 3 with no recorded source, 2 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections

Sources (as of 2026-09-12), by section of the research

  • Summary at the top of the page: Business description; Annual revenue and net result (USD millions); Quarterly income statement (USD thousands); Cash, investments and debt
  • 1. What is MetLife (MET), and what does it report?: Business description; Revenue by segment; Quarterly income statement (USD thousands); Reported versus estimated, last 8 quarters
  • 2. What do the latest results show for MetLife (MET)?: Quarterly income statement (USD thousands); Reported versus estimated, last 8 quarters; Management outlook — dated call excerpts; Most recent periodic reports
  • 3. What are the financial strengths and risks for MetLife (MET)?: Operating cash flow by quarter (USD millions); Cash, investments and debt; Cash and investment components; Cash and short-term investments over time (USD millions); Annual revenue and net result (USD millions); Quarterly income statement (USD thousands); Trailing twelve-month ratio set; Distress and quality screens
  • 4. What should you watch next at MetLife (MET)?: Management outlook — dated call excerpts; Next earnings report; Analyst revenue and earnings estimates (average); Reported versus estimated, last 8 quarters; Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions)
  • 5. How does MetLife compare with its peers?: Sector / industry (provider taxonomy); Business description; Revenue by segment; Cash, investments and debt; Trailing twelve-month ratio set
  • FAQ: What does MetLife Group Benefits sell to employers?: Business description; Named officers; Revenue by segment
  • FAQ: Why do private-equity returns matter to MetLife earnings?: Business description; Cash and investment components; Management outlook — dated call excerpts
  • FAQ: Is MetLife Holdings the same as the operating insurance business?: Business description; Named officers
  • FAQ: Do MetLife insider records show open-market buying?: Insider transactions, last 180 days
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.

ETFs that hold MET

Funds in our ETF coverage that list MET among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.

ETFWeightHoldings as of
RWW ETF3.84%